Carlin Consumer Health Acquires Zegerid OTC from Bayer

Cooper Consumer Health Acquires Viatris' Over-the-Counter Business

July 3, 2024

Pharmaceuticals

Cooper Consumer Health has completed the acquisition of the Over-the-Counter (OTC) business of Viatris Inc., following regulatory approvals and worker council consultations. The deal brings more than 200 brands (including Betadine, Saugella, Armolipid and CB12), two manufacturing sites in Mérignac (France) and Confienza (Italy) and an R&D centre in Monza (Italy) into Cooper's platform, doubling Cooper's revenues to approximately €1.2bn.

Carlin Consumer Health Acquires Penetrex from Wellbeam Consumer Health

April 30, 2024

Consumer Products

Carlin Consumer Health, a PE-backed consumer health platform sponsored by Hildred Capital, Bourne Partners Strategic Capital and The Emerson Group, has acquired the Penetrex joint and muscle care brand from Wellbeam Consumer Health. Financial terms were not disclosed; Penetrex will be added to Carlin's portfolio of over-the-counter (OTC) consumer health brands to support growth and retail/eCommerce distribution.

Carlin Consumer Health Acquires Infirst USA Holdings, LLC

October 24, 2023

Consumer Products

Carlin Consumer Health, a PE‑sponsored consumer health platform, has acquired Infirst USA Holdings, LLC, the parent of Infirst Healthcare Inc., the marketer of Mylanta and Mylicon under license from McNeil Consumer Pharmaceuticals. Infirst will become a wholly owned subsidiary of Carlin; the company is based in Westport, Connecticut and ships from a warehouse in Plainfield, Indiana. Financial terms were not disclosed.

Norwell Consumer Healthcare Acquires Boyd Pharmaceuticals' Canadian OTC Brands

July 5, 2023

Pharmaceuticals

Norwell Consumer Healthcare Inc. has entered a definitive agreement to acquire a portfolio of assets from Boyd Pharmaceuticals, including the Colace, Colace Glycerin, Dequadin, Allenburys and Gelusil brands in Canada. The asset purchase strengthens Norwell's gastroenterology and cough & cold portfolio and supports accelerated growth of its consumer OTC business.

WellSpring Consumer Healthcare Acquires A+D, Solarcaine and Other OTC Skin Care Brands from Bayer

April 4, 2023

Consumer Products

WellSpring Consumer Healthcare, a portfolio company of Avista Capital Partners, acquired a portfolio of OTC skin care brands from Bayer AG — including A+D, Solarcaine, Cortate and Complex 15 — to expand scale, product diversity and accelerate its innovation pipeline. Financial terms were not disclosed; the transaction is described as WellSpring's first add-on acquisition since Avista's investment in August 2022.

Hildred Capital Management Acquires Hello Bello

December 19, 2023

Consumer Products

Hildred Capital Management has agreed to acquire Hello Bello, a premium yet affordable baby and family care brand, through a Chapter 11 sale process. Hildred will transition Hello Bello into its portfolio under Hyland's Naturals to build a larger pediatric consumer health platform and accelerate manufacturing, distribution, and growth.